News

Published on 31 Jan 2025 on Investing.com

U.S. stocks lower at close of trade; Dow Jones Industrial Average down 0.75% By...


Article preview image

U.S. stocks lower at close of trade; Dow Jones Industrial Average down 0.75%

NASDAQ.AMGN price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
4 Healthcare Stocks Poised to Crush Q4 Earnings Estimates

Rising patient volumes, technological advancements, rate hikes and other factors are likely to ha...

Zacks · via Yahoo Finance 31 Jan 2025

U.S. stocks lower at close of trade; Dow Jones Industrial Average down 0.75% By...

U.S. stocks lower at close of trade; Dow Jones Industrial Average down 0.75%

Investing.com 31 Jan 2025

Is Amgen Inc. (AMGN) a Cheap Quarterly Dividend Stock to Invest In?

We recently compiled a list of the 7 Cheap Quarterly Dividend Stocks to Invest in. In this articl...

Insider Monkey · via Yahoo Finance 31 Jan 2025

Amgen's SWOT analysis: stock outlook amid obesity drug race, pipeline progress...

Amgen's SWOT analysis: stock outlook amid obesity drug race, pipeline progress

Investing.com 30 Jan 2025

Is Regeneron Pharmaceuticals (REGN) Among the Best Depressed Stocks to Invest in...

We recently published a list of 12 Best Depressed Stocks to Invest in Now. In this article, we ar...

Insider Monkey · via Yahoo Finance 28 Jan 2025

Study Unveils Key Immune Cells Found to Boost Cancer Treatment Success in Acute...

New York, NY—January 24, 2025— A research team from Columbia Engineering and the Irving Institute...

Columbia University News 24 Jan 2025

Is Regeneron Pharmaceuticals, Inc. (REGN) the Best Falling Stock to Invest in...

We recently published a list of 10 Best Falling Stocks to Invest in Right Now. In this article, w...

Insider Monkey · via Yahoo Finance 24 Jan 2025

Amgen's SWOT analysis: stock poised for growth amid obesity drug potential By...

According to InvestingPro data, the company maintains a "GOOD" overall financial health score,...

Investing.com 23 Jan 2025

Cytokinetics Heart Drug's Future Sparks Optimism Despite M&A Hurdles and Royalty...

However, last year, Novartis AG (NYSE:NVS) decided to step back from pursuing the Cytokinetics de...

Benzinga · via Yahoo Finance 22 Jan 2025

Amgen Inc. (AMGN): A Bull Case Theory

We came across a bullish thesis on Amgen Inc. (AMGN) on Disruptive analytics’ Substack by Magnus ...

Insider Monkey · via Yahoo Finance 20 Jan 2025